Find Grants for Municipalities, Political Subdivisions, and State Governments

Find out if you qualify for verified grants for Municipalities, Political Subdivisions, and State Governments . Discover your eligibility and key funding details for Municipalities, Political Subdivisions, and State Governments from major foundations and government agencies.

Total Dollars Available
$ 100 Trillion

Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)

Deadline: April 8, 2029


Opportunity Number: PA-27-037

Agency: National Institutes of Health

Open Date: June 16, 2026

Close Date: April 8, 2029

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.867, 93.398, 93.866, 93.113, 93.310, 93.853, 93.THR, 93.846, 93.172, 93.213, 93.855, 93.T21, 93.279, 93.121, 93.173, 93.242, 93.859

Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)

Deadline: February 10, 2027


Opportunity Number: RFA-DK-27-119

Agency: National Institutes of Health

Open Date: June 16, 2026

Close Date: February 10, 2027

Status: Posted

CFDA Numbers: 93.847

FY26 Bureau of Land Management Youth Conservation Corps - Bureau wide      

Deadline: October 16, 2026


Opportunity Number: L26AS00064

Agency: Bureau of Land Management

Open Date: June 12, 2026

Close Date: October 16, 2026

Status: Posted

CFDA Numbers: 15.243

F26AS00083 Aquatic Invasive Species Grants to Great Lakes States - Fiscal Year 2026 Great Lakes Restoration Initiative

Deadline: December 31, 2026


Opportunity Number: F26AS00083

Agency: Fish and Wildlife Service

Open Date: June 10, 2026

Close Date: December 31, 2026

Status: Posted

CFDA Numbers: 15.662

Southwest Border Resource Protection Program

Deadline: September 8, 2026


Opportunity Number: P26AS00060

Agency: National Park Service

Open Date: June 10, 2026

Close Date: September 8, 2026

Status: Posted

CFDA Numbers: 15.963

Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)

Deadline: September 25, 2028


Opportunity Number: PAR-27-026

Agency: National Institutes of Health

Open Date: June 9, 2026

Close Date: September 25, 2028

Status: Posted

CFDA Numbers: 93.279

Science Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)

Deadline: March 16, 2029


Opportunity Number: PAS-27-028

Agency: National Institutes of Health

Open Date: June 9, 2026

Close Date: March 16, 2029

Status: Posted

CFDA Numbers: 93.279

Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)

Deadline: January 29, 2029


Opportunity Number: PAR-27-024

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: January 29, 2029

Status: Posted

CFDA Numbers: 93.859

NIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)

Deadline: May 25, 2029


Opportunity Number: PA-27-034

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: May 25, 2029

Status: Posted

CFDA Numbers: 93.172, 93.361, 93.865, 93.855, 93.242, 93.859, 93.279, 93.839, 93.273, 93.113, 93.310, 93.847, 93.173, 93.853, 93.867, 93.121, 93.840, 93.837, 93.866, 93.398, 93.T21, 93.233, 93.838, 93.313, 93.879

NIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)

Deadline: May 5, 2029


Opportunity Number: PA-27-036

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: May 5, 2029

Status: Posted

CFDA Numbers: 93.859, 93.310, 93.853, 93.879, 93.279, 93.173, 93.273, 93.313, 93.837, 93.242, 93.361, 93.840, 93.866, 93.398, 93.839, 93.THR, 93.847, 93.855, 93.865, 93.113, 93.838, 93.172, 93.233, 93.121, 93.867, 93.T21

NIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)

Deadline: May 5, 2029


Opportunity Number: PA-27-035

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: May 5, 2029

Status: Posted

CFDA Numbers: 93.172, 93.398, 93.313, 93.837, 93.853, 93.121, 93.310, 93.T21, 93.847, 93.233, 93.866, 93.279, 93.838, 93.173, 93.242, 93.855, 93.867, 93.361, 93.839, 93.859, 93.273, 93.840, 93.394

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

Deadline: October 9, 2026


Opportunity Number: RFA-DK-27-121

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: October 9, 2026

Status: Posted

CFDA Numbers: 93.847

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)

Deadline: October 9, 2026


Opportunity Number: RFA-DK-27-136

Agency: National Institutes of Health

Open Date: June 8, 2026

Close Date: October 9, 2026

Status: Posted

CFDA Numbers: 93.847

Outdoor Recreation Legacy Partnership Program (ORLP) Recurring Notice 5 Year

Deadline: November 1, 2030


Opportunity Number: P26AS00125

Agency: National Park Service

Open Date: June 8, 2026

Close Date: November 1, 2030

Status: Posted

CFDA Numbers: 15.916

Readiness and Recreation Initiative (RARI) – Recurring 5 Year Notice

Deadline: November 30, 2030


Opportunity Number: P26AS00146

Agency: National Park Service

Open Date: June 8, 2026

Close Date: November 30, 2030

Status: Posted

CFDA Numbers: 15.916

Home Study and Post-Release Services for Unaccompanied Alien Children​​

Deadline: October 1, 2027


Opportunity Number: HHS-2026-ACF-ORR-ZU-0019

Agency: Administration for Children and Families - ORR

Open Date: June 5, 2026

Close Date: October 1, 2027

Status: Posted

CFDA Numbers: 93.676

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

Deadline: July 5, 2029


Opportunity Number: PAR-27-057

Agency: National Institutes of Health

Open Date: June 4, 2026

Close Date: July 5, 2029

Status: Posted

CFDA Numbers: 93.121

Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)

Deadline: March 10, 2027


Opportunity Number: RFA-DK-27-108

Agency: National Institutes of Health

Open Date: June 4, 2026

Close Date: March 10, 2027

Status: Posted

CFDA Numbers: 93.838, 93.233, 93.847, 93.839, 93.840, 93.837

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Deadline: February 9, 2029


Opportunity Number: RFA-DA-27-016

Agency: National Institutes of Health

Open Date: June 4, 2026

Close Date: February 9, 2029

Status: Posted

CFDA Numbers: 93.279, 93.213, 93.273, 93.866

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Deadline: September 25, 2026


Opportunity Number: RFA-CA-27-012

Agency: National Institutes of Health

Open Date: June 4, 2026

Close Date: September 25, 2026

Status: Posted

CFDA Numbers: 93.396

Partnership Agreement Grants, FY 2027

Deadline: September 29, 2026


Opportunity Number: 2027NEA04PA

Agency: National Endowment for the Arts

Open Date: June 4, 2026

Close Date: September 29, 2026

Status: Posted

CFDA Numbers: 45.025

Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) - Resource Center (U24 Clinical Trial Not Allowed)

Deadline: September 30, 2026


Opportunity Number: RFA-DK-27-109

Agency: National Institutes of Health

Open Date: June 4, 2026

Close Date: September 30, 2026

Status: Posted

CFDA Numbers: 93.837, 93.233, 93.840, 93.838, 93.839, 93.847, 93.310

Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

Deadline: November 10, 2026


Opportunity Number: RFA-CA-27-002

Agency: National Institutes of Health

Open Date: June 3, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.394

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

Deadline: November 10, 2026


Opportunity Number: RFA-CA-27-001

Agency: National Institutes of Health

Open Date: June 3, 2026

Close Date: November 10, 2026

Status: Posted

CFDA Numbers: 93.394

Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)

Deadline: October 2, 2026


Opportunity Number: RFA-HD-27-006

Agency: National Institutes of Health

Open Date: June 3, 2026

Close Date: October 2, 2026

Status: Posted

CFDA Numbers: 93.865

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.